Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Plans FDA Submissions in May or June for Troponin Test

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Beckman Coulter today said that it anticipates filing for US clearance on its troponin test during May or June.

In a document filed with the US Securities and Exchange Commission, the Orange County, Calif.-based firm said that it plans to file two separate 510(k) applications with the FDA for the troponin test, one to be run on its Access instruments, the other on its Dxl instruments. Its time estimate is based on the current status of its clinical trial for the test, including site and patient enrolment, and preliminary myocardial infarction incidence rates observed.

Beckman Coulter had previously stated that it anticipated submitting to the FDA for the troponin test in the first half of this year.

The test had run into quality control problems a year ago when the company informed customers of a positive bias in results for its troponin test kits running on its UniCel Dxl immunoassay system.

Beckman Coulter is reportedly in the process of shopping for a buyer in a deal that could fetch $5 billion.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.